Fexofenadine hydrochloride 180mg

Soft capsules

Novolegic is indicated for the relief of symptoms associated with seasonal allergic rhinitis in
adults and children 6 years of age and older and  indicated for treatment of uncomplicated skin manifestations of chronic idiopathic
urticaria in adults and children 6 years of age and older

Posology

Adults

The recommended dose of fexofenadine hydrochloride for adults is 180 mg once daily taken before a meal.

Fexofenadine is a pharmacologically active metabolite of terfenadine.

Paediatric population

Adolescents aged 12 years and over

The recommended dose of fexofenadine hydrochloride for adolescents aged 12 years and over is 180 mg once daily taken before a meal.

Children under 12 years of age

The efficacy and safety of fexofenadine hydrochloride 180 mg has not been studied in children under 12.

Special populations

Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.

Method of administration

Fexofenadine hydrochloride tablet is for oral use.